 |
26 Diseases |  |
7 Trials |
|
7 Trials |  |
4331 News |  |
| «12...1213141516171819202122...5051» |
- ||| icosapent ethyl / Generic mfg.
#VASCEPA discussed on the Joe Rogan show with Dr. Rhonda Patrick, starting at 103:40 👇 https://t.co/BLV3H5ylSt PS Vascepa is also studied for COVID in PREPARE-IT. @foundmyfitness @joerogan @DLBHATTMD @VietHeartPA @drpablocorral @TerraPharma1 @Amarincorp $AMRN @mmillermd1 (Twitter) - Aug 26, 2021
- ||| icosapent ethyl / Generic mfg.
REDUCE-IT PRIOR MI - significant reductions in cardiovascular death, cardiac arrest, and sudden cardiac death with icosapent ethyl. Details in the #ESCAbstract at the #ESCCongress. https://t.co/bMcyXTnivT via @escardio. #cardiotwitter @gabrielsteg @mmillermd1 @CMichaelGibson (Twitter) - Aug 26, 2021
- |||| icosapent ethyl / Generic mfg.
Clinical, Adverse events: The REDUCE-IT results support that approximately 1 fewer major cardiovascular adverse event would occur on average for every 6 patients treated with Vascepa for 5 years on top of statin therapy compared to placebo. “Add it to a statin!” @escardio @SCC_CCS @DLBHATTMD (Twitter) - Aug 26, 2021
- |||| icosapent ethyl / Generic mfg.
Clinical: Thx. When do we get data from the PREPARE-IT 2 ( treatment arm ) . ? Those of us that are CAD and on Vascepa want to know if Vascepa will reduce risk of hospitalization and death from Covid You are involved in the P-It trials ..correct ? (Twitter) - Aug 26, 2021
- ||||| icosapent ethyl / Generic mfg.
Clinical: The REDUCE-IT trial showed that icosapent ethyl was superior to placebo in reducing triglycerides, cardiovascular events, and cardiovascular death among patients with high triglycerides and known or high risk of #CVD. https://t.co/1hOBgzG4gM #ESCCongress @DLBHATTMD @keaglemd (Twitter) - Aug 26, 2021
- |||| icosapent ethyl / Generic mfg.
Clinical: Completely agree. Very telling why they are doing multiple clinical trials at the moment for Vascepa on covid. #amarin #vascepa (Twitter) - Aug 26, 2021
- ||||| icosapent ethyl / Generic mfg.
Clinical: Introducing the panel for @heartindiabetes #CMESymposium "The Evloving Therapeutic Role of Icosapent Ethyl: IPE in ASCVD and Beyond" supported by @Amarincorp. Join the Panel Q&A on Friday, September 10, 2021. Learn more at https://t.co/6633vf3gJk @BudoffMd @UCLAHealth #cardioed (Twitter) - Aug 26, 2021
- ||||| icosapent ethyl / Generic mfg.
Enrollment closed, Trial primary completion date: PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial (clinicaltrials.gov) - Aug 26, 2021
P3, N=4000, Active, not recruiting, Sponsor: Estudios Clínicos Latino América
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2021 --> Aug 2021
- |||| icosapent ethyl / Generic mfg.
⚠️REDUCE-IT PRIOR MI: ⤵️ CV☠️, with Icosapent Ethyl in 👥 with Prior MI 👉4 g/day significantly ⤵️ first & total primary endpoints by 26% & 35%, respectively, in 👥 with prior Ml 👉Icosapent ethyl led ⤵️Ml, CV☠️, sudden cardiac ☠️, and cardiac arrest @DLBHATTMD #ESCCongress (Twitter) - Aug 25, 2021
- ||| fluvoxamine / Generic mfg., icosapent ethyl / Generic mfg.
#COVID19 #fluvoxamine 比較的大きなフルボキサミンの研究がmedrxivに投稿されてました。結果はいまいち。icosapent ethylを使ったPREPARE-ITはこれよりも結果が良いことを祈る。@drpablorcorral @ferbotto @DLBHATTMD https://t.co/HfywCI6Msi (Twitter) - Aug 24, 2021
- |||| icosapent ethyl / Generic mfg.
Dr. @yhandelsmanmd, Dr. @BudoffMd, and Dr. Peter Toth will be presenting for @heartindiabetes #CMESymposium "The Evloving Therapeutic Role of Icosapent Ethyl: IPE in ASCVD and Beyond" supported by @Amarincorp on Friday, September 10, 2021. Learn more at https://t.co/nHguWrumHv (Twitter) - Aug 24, 2021
- ||| icosapent ethyl / Generic mfg.
Dr. @yhandelsmanmd, Dr. @BudoffMd, and Dr. Peter Toth will be presenting for #HID2021 CME Symposium "The Evloving Therapeutic Role of Icosapent Ethyl: IPE in ASCVD and Beyond" supported by @Amarincorp on Friday, September 10, 2021 at 8:30am. Learn more at https://t.co/5tuugbjFec (Twitter) - Aug 24, 2021
- |||| icosapent ethyl / Generic mfg.
Dr. Matthew @BudoffMd, Dr. Peter Toth, and I will be presenting for @heartindiabetes #CMESymposium "The Evloving Therapeutic Role of Icosapent Ethyl: IPE in ASCVD and Beyond" supported by @Amarincorp on Friday, September 10, 2021 at 8:30am. Learn more at https://t.co/6633vf3gJk (Twitter) - Aug 24, 2021
- || icosapent ethyl / Generic mfg.
#Vacespa and soon #Vazkepa in the EU after years of rigorous research and science. @Amarincorp Reduce-it and Prepare-it with the statin combo can be a huge change in our CV health. (Twitter) - Aug 24, 2021
- || icosapent ethyl / Generic mfg.
Yes, and be sure to include VASCEPA along with statins to REDUCE the risk of a CVE by an additional 25% above stain alone therapy. (Twitter) - Aug 23, 2021
- |||| icosapent ethyl / Generic mfg.
Clinical: Waiting impatiently for Prepare-It data !!! Expecting some big news showing a positive effect of #vascepa on Covid-19 patients (Twitter) - Aug 23, 2021
- ||||| icosapent ethyl / Generic mfg.
Clinical: Great #ESCCongress talk by @DLBHATTMD! A prespecified subanalysis of #REDUCEIT trial among patients with prior MI. Icosapent ethyl greatly reduced CV risk and mortality. https://t.co/Px9IgKOJQ0 via @escardio @gabrielsteg @mmamas1973 @SABOURETCardio @ESCardioNews (Twitter) - Aug 23, 2021
- ||||| icosapent (MND-2119) / Mochida, Amarin
Trial completion: Long-term Safety and Efficacy Study of MND-2119 in Patients With Hypertriglyceridemia (clinicaltrials.gov) - Aug 23, 2021
P3, N=120, Completed, Sponsor: Mochida Pharmaceutical Company, Ltd.
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2021 --> Aug 2021 Active, not recruiting --> Completed
- || icosapent ethyl / Generic mfg.
A comment in @ehj by @DLBHATTMD about the results of EVAPORATE and Reduce-It trial and the use of icosapent ethyl. #lowLDL #coronaryplaque #cardiotwitter https://t.co/yMch54vbAL (Twitter) - Aug 22, 2021
- || icosapent ethyl / Generic mfg.
The biggest change in the guidelines IMO is the recognition that TG’s over 1.5 is a red flag for CVD and should be treated with icosapent ethyl #Vascepa a whole new treatment option that has shown 25% RRR in MACE in @DLBHATTMD ‘s REDUCE-IT trial @SCC_CCS (Twitter) - Aug 21, 2021
- ||| Influvac (influenza virus surface antigens) / Abbott
👍 Excellent synthesis by @DLBHATTMD ➡️ What will happen at #ESCCongress next week? I'll add to the list the WHF largest worldwide Covid and CV disease registry ✅ Eyes open for colchicine, Vascepa, influVac, Tica, and Empa (Twitter) - Aug 20, 2021
- || icosapent ethyl / Generic mfg.
@DLBHATTMD https://t.co/vuYpeCIiNf May be that Vascepa can also help we will have to wait for the results next week (Twitter) - Aug 20, 2021
- ||| icosapent ethyl / Generic mfg.
Clinical: EVAPORATE trial provides important mechanistic data on plaque characteristics that have relevance to the REDUCE-IT results and clinical use of icosapent ethyl https://t.co/eVY3r6Lctu @BudoffMd @SuvasiniL #CardioTwitter #prevention (Twitter) - Aug 20, 2021
- ||| icosapent ethyl / Generic mfg.
Thank you @DrOz & @DrMikeRoizen for mentioning Icosapent Ethyl (VASCEPA). In additional to the 25% CVD risk reduction, VASCEPA is being studied for #COVID via PREPARE-IT trial, data release @ ESC on Aug 29. @DLBHATTMD @drpablocorral @VietHeartPA $AMRN https://t.co/04fn1GtdMX (Twitter) - Aug 17, 2021
- |||| icosapent ethyl / Generic mfg.
Clinical: $AMRN Amarin : LATEST CLINICAL RESEARCH EVALUATING VASCEPA/VAZKEPA IN PATIENTS WITH RESIDUAL CARDIOVASCULAR RISK ... https://t.co/eRnRGOfYJp @Amarincorp @drpablocorral @DLBHATTMD (Twitter) - Aug 17, 2021
- ||| icosapent ethyl / Generic mfg., fenofibrate / Generic mfg.
@MartyMakary @drpablocorral @DLBHATTMD @DrMarcSiegel FENOFIBRATE OR VASCEPA® FOR COVID? YOU MAKE THE CALL. https://t.co/6xPqyfqn6y (Twitter) - Aug 17, 2021
- || icosapent ethyl / Generic mfg.
Hey @PfizerCA now that you are promoting #Vascepa in 🇨🇦 you can start by telling people about the great presentations at ESC 2021 by @DLBHATTMD and @drpablocorral Sad that PREPARE-IT 2 will not be there but coming soon after I’m sure! @PPr_Plus @JeanCoutu (Twitter) - Aug 16, 2021
- || icosapent ethyl / Generic mfg.
Review, Journal: EPA's pleiotropic mechanisms of action: a narrative review. (Pubmed Central) - Aug 13, 2021
Treatment with icosapent ethyl 4 g/day, a highly purified and stable ethyl ester of eicosapentaenoic acid (EPA), demonstrated a significant reduction in atherosclerotic cardiovascular disease (ASCVD) events and death in REDUCE-IT...Clinically, this may translate into improved vascular health, including regression of atherosclerotic plaque. Overall, EPA has a range of pleiotropic effects that contribute to a reduction in ASCVD.
- || icosapent ethyl / Generic mfg.
Clinical, Journal: Applicability of the REDUCE-IT trial to the FAST-MI registry. Are the results of randomized trials relevant in routine clinical practice? (Pubmed Central) - Aug 12, 2021
Overall, EPA has a range of pleiotropic effects that contribute to a reduction in ASCVD. If the results of REDUCE-IT are applied to patients hospitalized for a myocardial infarction in France, 12.5% of these patients could benefit from a strategy of high-dose omega-3 icosapent ethyl on top of contemporary therapy including statins to improve their clinical outcomes.
- || icosapent ethyl / Generic mfg.
@drpablocorral @DLBHATTMD @BudoffMd @VietHeartPA @mmillermd1 @DrWoodcockFDA #VASCEPA (Twitter) - Aug 7, 2021
- icosapent ethyl / Generic mfg.
Veterans in AD Prevention Clinical Trials: An evaluation of the association of TBI on memory and global cognition () - Aug 7, 2021 - Abstract #CTAD2021CTAD_117;
P2/3
Increasing enrollment of Veterans into AD prevention clinical trials is critical in that they are at higher risk for AD than the general population. In this study, the probable TBI group was indistinguishable from the non-TBI group on baseline measures of memory and outperformed the non-TBI group on measure of global cognition.
- ||| icosapent ethyl / Generic mfg., fenofibrate / Generic mfg.
FDA event: Funny thing: After decades of use the FDA finally revoked their approval of Fenofibrates and Niacins because of their dangerous SE’s that outweighed any benefits they may have had. VASCEPA is safe and still FDA approved. 👍 (Twitter) - Aug 6, 2021
- ||| icosapent ethyl / Generic mfg.
"...inhibiting the harmful overproduction of cytokines tied to coronavirus infection, and also treat airway inflammation" #VASCEPA @drpablocorral @DLBHATTMD @BudoffMd @VietHeartPA @mmillermd1 @MarkBrady2014 $AMRN (Twitter) - Aug 6, 2021
- || icosapent ethyl / Generic mfg.
🚨 PREPARE-IT results around the corner but this is very interesting (& perhaps a foreshadow) 👇👇👇 #VASCEPA $AMRN https://t.co/DaoYxpUxV4 @drpablocorral @DLBHATTMD @BudoffMd @VietHeartPA @mmillermd1 (Twitter) - Aug 6, 2021
- |||| icosapent ethyl / Generic mfg.
Review: #NBNA2021 Great review of HTG by @DrRachelMBond during @ABCardio1 symposium: ➡️ LDL-C control is cornerstone ➡️ Residual #CV risk despite statins; non-statins useful ➡️ EPA preferred over DHA ➡️Pure EPA (#IcosapentEthyl) reduces #CV risk in REDUCE-IT trial @NbnaInc @kcferdmd (Twitter) - Aug 6, 2021
- ||| icosapent ethyl / Generic mfg.
Clinical: That's very impressive. Are you adding vascepa in patients like this when the TGs remain elevated? Or do you leave it alone? (Twitter) - Aug 6, 2021
- | icosapent ethyl / Generic mfg.
Journal: When to lower triglycerides? (Pubmed Central) - Aug 4, 2021
There is evidence for the benefits of IPE in preventing ASCVD events. A novel fibrate is in clinical trials.
- || icosapent ethyl / Generic mfg.
Husband and I have been on Vascepa for 3 years and have not even had a cold, which is unusual. 💚 Vascepa! (Twitter) - Aug 1, 2021
- ||| icosapent ethyl / Generic mfg.
4) the evidence of high dose pure EPA as IPE was shown to have a stat sig improvement in hsCRP, d-dimer levels and Pt symptoms in the CardioLink-9 Vascepa Covid trial here: https://t.co/277u0naURG (Twitter) - Aug 1, 2021
- || icosapent ethyl / Generic mfg.
I don’t know…it feels like you’re asking a lot of Amarin management. Maybe we let them take baby steps like saying the name of their drug Vascepa on social media. How about it Amarin? How about August is “Say Vascepa” month for Amarin? #Vascepa #notashamedtosavelives (Twitter) - Jul 31, 2021
- |||| icosapent ethyl / Generic mfg.
Hey @Amarincorp: Maybe this is a good lesson by @pfizer on how to promote #VASCEPA and PREPARE-IT, a #COVID trial that you are a collaborator of 👇👇👇 @drpablocorral @DLBHATTMD @mmillermd1 @VietHeartPA @BudoffMd @AlbertBourla $AMRN $PFE https://t.co/XpPwl8UOiU (Twitter) - Jul 31, 2021
- || icosapent ethyl / Generic mfg.
What about physicians who post Vascepa misinformation? #Nissen $AMRN (Twitter) - Jul 30, 2021
- || icosapent ethyl / Generic mfg.
Another test is industrially processed EPA-EE (Vascepa) dissolves Styrofoam. Fish oil does not. (Twitter) - Jul 29, 2021
- || icosapent ethyl / Generic mfg.
Review, Journal: A Fishy Topic: VITAL, REDUCE-IT, STRENGTH, and Beyond: Putting Omega-3 Fatty Acids into Practice in 2021. (Pubmed Central) - Jul 29, 2021
Experimental and in vitro data suggest that compared to DHA, EPA exhibits antioxidant, anti-inflammatory, and membrane stabilizing properties that enhance vascular function and CVD risk. Consequently, purified EPA appears to be the treatment of choice for high-risk patients with hypertriglyceridemia.
- ||| icosapent ethyl / Generic mfg.
Clinical: Interesting take on Icosapent Ethyl. @CardioNerds should host a Pro/Con debate! Topic: "Icosapent Ethyl is beneficial for secondary prevention in pts w CAD/DM" Pro: @DLBHATTMD Con: Dr. Steve Nissen (twitter handle?) https://t.co/0FW4ZMN5kz (Twitter) - Jul 27, 2021
- | icosapent ethyl / Generic mfg.
Enrollment closed, Preclinical, Trial completion date, Trial primary completion date: BRAVE-EPA: Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid (clinicaltrials.gov) - Jul 26, 2021
P2/3, N=150, Active, not recruiting, Sponsor: VA Office of Research and Development
Consequently, purified EPA appears to be the treatment of choice for high-risk patients with hypertriglyceridemia. Recruiting --> Active, not recruiting | Trial completion date: Nov 2021 --> Jan 2023 | Trial primary completion date: Nov 2021 --> Jan 2023
- || icosapent ethyl / Generic mfg.
Does Vascepa help with that? (Twitter) - Jul 25, 2021
- || icosapent ethyl / Generic mfg.
No response necessary but I am extremely curious if it gets frustrating for scientists/investigators/doctors to keep pushing Icosapent Ethyl / #Vascepa, while $AMRN doesn't seem to do anything publicly to promote it. @DLBHATTMD @mmillermd1 @BudoffMd @VietHeartPA @drpablocorral (Twitter) - Jul 24, 2021
- || icosapent ethyl / Generic mfg.
Vascepa (pharma-grade EPA) Significantly Reduces Coronary Plaque in EVAPORATE Study. 2020 https://t.co/RpKOGTT25Z (Twitter) - Jul 24, 2021
- || icosapent ethyl / Generic mfg.
VASCEPA! (Twitter) - Jul 24, 2021